Skip to main content

Danaher Corp (DHR)

Sector
Health Care
Industry
Life Sciences Tools & Services
Last price
$224.69
As of

Kresmion compiles this page from DHR's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

DANAHER CORP /DE/ (DHR): 9 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-13.

As of . Source: SEC EDGAR filings for DHR. Method and limitations.

COMPANY DOSSIER

See the full DHR dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for DHR on one page. Preview it with sample data, then open it live with a free account.

Preview the DHR dossier

Active signals for DHR

FREE, NO ACCOUNT

Every signal on DHR, as it fires

You are seeing 5 of 51 signals recorded on DHR since 2026-05-05.

The five above landed across 2 days. The other 46 were recorded on 6 other days. 41 of the 51 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in DHR (2026Q2)

Manager / securityMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLCCUSIP 235851102 · 2026Q2$407.7M0.15%,
CITADEL ADVISORS LLCCUSIP 235851102 · 2026Q2$179.8M0.02%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 235851102 · 2026Q2$144.9M0.20%,
Third Point LLCCUSIP 235851102 · 2026Q2$102.9M2.20%,
TIGER GLOBAL MANAGEMENT LLCCUSIP 235851102 · 2026Q2$86.9M0.36%,
TWO SIGMA INVESTMENTS, LPCUSIP 235851102 · 2026Q2$86.2M0.06%,
D. E. Shaw & Co., Inc.CUSIP 235851102 · 2026Q2$78.5M0.04%,
Bridgewater Associates, LPCUSIP 235851102 · 2026Q2$4.9M0.02%,
Point72 Asset Management, L.P.CUSIP 235851102 · 2026Q2$2.2M0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, DHR

DHR against its peers

DHR's operating margin of 19.1% ranks in the 81st percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.

MetricDHRPeer medianPercentilen
Revenue FY24.6B USD1.2B USD9425
Gross margin59.1%55.5%5411
Operating margin19.1%-3.8%8123
Net margin14.7%-3.6%7125
Return on equity6.9%-5.0%6624
P / E44.5x40.6x5411
1 year9.0%28.0%1325

Peers (25): TMO, A, IQV, WAT, ILMN, MTD, MEDP, CRL, TEM, TECH, RGEN, AVTR, TXG, BRKR, SHC, ADPT, ABCL, FTRE, MRVI, DNA, MLAB, CTKB, OABI, PACB, CDXS. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (DHR: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Follow DHR on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to DHR for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the DHR dossier
Share

The DHR intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.